Page last updated: 2024-10-23

azathioprine and Adenofibroma

azathioprine has been researched along with Adenofibroma in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Adenofibroma: A benign neoplasm composed of glandular and fibrous tissues, with a relatively large proportion of glands. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dargent, M1
Bourgoin, JJ1
Noel, P1
Weissbrod, R1

Other Studies

1 other study available for azathioprine and Adenofibroma

ArticleYear
The influence of azathioprine on tumorogenesis by 7-12 dimethylbenz (a) anthracene in rats.
    European journal of cancer, 1972, Volume: 8, Issue:6

    Topics: Adenocarcinoma; Adenofibroma; Animals; Azathioprine; Benz(a)Anthracenes; Carcinoma; Female; Fibroma;

1972